Pay in 4 interest-free payments of $7.28 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
PMID 39994346
PubMed laboratory research record [PMID: 35258841] PubMed record related to this compound for laboratory literature review
Published protocols provide starting points for: Topical application frequencies (often once or twice daily) Subcutaneous injection volumes and concentrations near wound sites Systemic dosing regimens in organ injury models Treatment durations (typically 7-28 days for wound studies) Key Outcome Measures Established outcome measures in rodent GHK-Cu research include: Experimental Design Recommendations Future studies should incorporate: Careful monitoring of copper status throughout treatment periods Appropriate control groups including vehicle control, copper-free peptide control, and free copper controls where relevant Detailed methodology reporting for reproducibility Assessment of potential off-target effects through standard toxicology panels Consideration of sex differences, given that some regenerative processes show sex-dependent responses Researchers interested in overall skin health, skin rejuvenation, or anti aging mechanisms may also consider combining GHK-Cu with other peptides or active ingredients (such as vitamin c or chemical peels in post procedure recovery models) to examine synergistic effects
The 100 mg quantity in this listing is much larger than the 5 to 20 mg typical elsewhere in the catalog, and the reason is straightforward: the published work uses this compound at micromolar to millimolar working concentrations rather than the nanomolar concentrations at which receptor agonists are studied, and formulation and matrix-stability work consumes material quickly
Anisimov VN, Bondarenko LA, Khavinson VKh
